CClinicalTrials.gg
CompletedNCT06031701Updated Jan 17, 2024

Neuro-psychosocial Teleassistance for Neuromuscular Diseases

An interventional study of Neuro-psychosocial teleassistance program in Social Competence, Self Esteem and Quality of Life, sponsored by University of Deusto. Completed at 1 site in Spain. Open to participants aged 7 Years to 16 Years. Per ClinicalTrials.gov, last updated 2024-01-17.

Sponsored by University of Deusto · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 8 months after the study started (first participant enrolled Nov 2021, registered Jul 2023).
Phase
Not applicable
Study type
Interventional
Enrollment
35
Allocation
Non-randomized
Ages
7 Years to 16 Years
Sex
All
01

Study summary

This is a clinical trial to assess the effect of a neuropsychosocial intervention by means of telecare aimed at children and adolescents aged 7-16 years with neuromuscular diseases. The intervention is carried out in groups of 5 participants and is organised in 12 sessions: 1 session per week of 1h duration. The intervention is aimed at strengthening aspects of social cognition, self-esteem, social skills and aims at a reduction of symptomatology and a general improvement of psychological well-being.

Read the detailed description

Development of a neuro-psychosocial tele-assistance programme for groups of children and adolescents affected by various neuromuscular diseases, including Duchenne/Becker muscular dystrophy, limb-girdle dystrophy, etc. In this project the variables of interest and intervention include social cognition, quality of life, psychological symptomatology and coping strategies. The aim of this study is to test whether this programme improves the indicators in the mentioned variables.

02

Conditions studied

  • Social Competence
  • Self Esteem
  • Quality of Life
  • Social Skills
  • Neuromuscular Diseases
03

In context

Neuromuscular Diseases

300 studies on the registry are indexed under Neuromuscular Diseases; 87 are open to participants now.

This study's enrollment of 35 is close to the median of 32 across 168 interventional studies indexed under Neuromuscular Diseases.

Browse Neuromuscular Diseases studies →

Lead sponsor

University of Deusto is the lead sponsor of 20 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
7 Years to 16 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • To be diagnosed with a neuromuscular disease by a specialist
  • Being between 7 and 16 years old
  • Having signed an informed consent form through their legal guardians prior to participation in the study
  • Having Spanish as one of their main languages
  • Having access to a computer (with a camera, microphone and speakers integrated) and Internet connection to take part in the videoconferences

Exclusion criteria

Exclusion Criteria:

  • Presence of any other diagnosis or sensory deficit that would prevent the application of the tests or hinder the correct performance of the intervention´s activities
  • Being illiterate
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
35 participants (actual)

Study arms

  • Experimental
    Intervention

    Neuro-psychosocial intervention with 12 grupal sessions is offered

    Behavioral: Neuro-psychosocial teleassistance program

  • Experimental
    Control

    Waiting list control group

    Behavioral: Neuro-psychosocial teleassistance program

Interventions

  • BehavioralNeuro-psychosocial teleassistance program

    The intervention is carried out in groups of 5 participants and is organised in 12 sessions: 1 session per week of 1h duration. The intervention is aimed at strengthening aspects of social cognition, self-esteem, social skills and aims at a reduction of symptomatology and a general improvement of psychological well-being.

06

What researchers measure

Primary outcomes

  1. Social cognition - Emotion Recognition

    Affect Recognition subtest of the Social Perception Domain of the NEPSY-II in the Spanish edition (Korkman et al., 2014) measures the capacity to identify emotions (happy, sad, neutral, afraid, irrationally angry, and disgust) in various images of children

    Time frame: 3 months after the intervention

  2. Social cognition - Theory of mind - NEPSY-II

    Theory of Mind subtest of the Social Perception Domain of the NEPSY-II in the Spanish edition (Korkman et al., 2014) assesses figurative language, imitation skills, and the capacity to comprehend the thoughts, ideas, and beliefs of others and it also evaluates a person's capacity to comprehend how emotions relate to the social context.

    Time frame: 3 months after the intervention

  3. Social cognition - Theory of mind - Happé's Strange Stories

    The Happé's Strange Stories Test is a well-known test of ToM (Happé, 1994; Spanish version: Pousa, 2002). In this study, we used the White et al. (2009) version that has eight story-types. This test evaluates participants capacity to comprehend nonliteral meanings through the reading of brief vignettes.

    Time frame: 3 months after the intervention

  4. Social cognition - Theory of mind - RMETC

    The Reading the Mind in the Eyes test Child version (RMETC) (Baron-Cohen et al., 2001; Spanish version: Rueda et al., 2013), is a TOM test that features 28 photos of individuals. The participant's task is to match the picture with one of the four adjectives that best describes the feelings and thoughts of the person in the picture.

    Time frame: 3 months after the intervention

Secondary outcomes

  1. Health-related quality of life

    How an individual's health status impacts their overall well-being and ability to lead a satisfying life The perception of HRQoL is assessed in both healthy and chronically ill children using the Spanish version of the Pediatric Quality of Life Inventory (PedsQLTM 4.0) (Varni et al., 2001). We used the self-report questionnaire in this study for three age ranges: 5-7, 8-12, and 13-18. Physical functioning, emotional functioning, social functioning, and academic functioning are the four dimensions covered by the 23-item assessment. The PedsQL 4.0 provides a physical and a psychosocial summary score in addition to a total score. It is answered through a likert scale with 5 response options that are then converted into quantitative scores ranging from 0-100 points, with a higher score being a better HRQoL.

    Time frame: 3 months after the intervention

  2. Psychopathology

    Behavioral and emotional symptoms The Child Behavior Checklist for Ages 6-18 (CBCL/6-18) (Achenbach \& Rescorla, 2001) is a multiaxial assessment tool for identifying behavioral and emotional issues in children and adolescents that is aligned with the ASEBA (Achenbach System of Empirically Based Assessment). It has 113 items total, broken down into eight scales for the following syndromes: anxious/depressed, withdrawn/depressed, somatic complaints, social problems, thinking problems, attention problems, rule-breaking behavior and aggressive behavior. Scores for internalizing, externalizing, and overall difficulties are also provided by the items.

    Time frame: 3 months after the intervention

  3. Coping strategies - EAN

    Different styles to deal with stressful situations Coping Scale for Children (EAN) (Morales-Rodríguez et al., 2012) is a self-report scale assesses coping strategies and is intended for children aged nine to 12 years. In the instrument, four problems related to the family context, health, schoolwork and social relationships are posed. The nine coping strategies assessed are distinguished between problem-focused coping and unproductive coping.

    Time frame: 3 months after the intervention

  4. Coping strategies - ACS

    Different styles to deal with stressful situations Adolescent Coping Scales (ACS) (3rd edition) (Frydenberg and Lewis, 2000): assesses different coping strategies in adolescents aged 12-18 years to cope with their problems. The inventory assesses 18 different coping strategies and consists of 80 items, 79 closed-ended and one open-ended. Furthermore, the 18 strategies are classified into three basic coping styles: problem-directed coping, coping in relation to others, and unproductive coping.

    Time frame: 3 months after the intervention

07

Study locations

1 site
  • University of Deusto
    Bilbao, Bizkaia 48007, Spain
08

References and documents

Individual participant data

Plan to share: Yes — The plan is open for other researchers to contact the principal investigator of the study.

Supporting information: Study protocol, Sap, Icf

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 17, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06031701
Lead sponsor
University of Deusto
Responsible party
Sponsor
First posted
Sep 11, 2023
Start date
Nov 2, 2021
Primary completion
Nov 30, 2022
Completion
Jun 30, 2023
Last update
Jan 17, 2024

Study contacts

Oscar Martínez, PhD
principal investigator · University of Deusto

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion